Van Thiel D H, Bonet H, Gavaler J, Wright H I
Oklahoma Transplant Institute, Baptist Medical Center of Oklahoma, Oklahoma City 73112, USA.
Alcohol Clin Exp Res. 1995 Oct;19(5):1151-5. doi: 10.1111/j.1530-0277.1995.tb01594.x.
Alcoholic liver disease is a major cause of liver disease and has become an ever-increasing indication for liver transplantation (LTx). Follow-up studies have reported a higher rate of alcohol recidivism in patients transplanted for alcoholic hepatitis, compared with those transplanted for endstage alcohol-associated cirrhosis. It is assumed widely that recurrent alcohol use is associated with reduced compliance with immune suppression and, as a result, an increased risk of graft rejection and loss. To assess this question, 209 alcoholic patients transplanted for either alcoholic hepatitis with cirrhosis or cirrhosis alone between January 1, 1986 and December 31, 1991 were followed, with a mean follow-up of 4.4 +/- 0.6 years. There were 175 episodes of acute cellular rejection (ACR) that occurred in 137 patients, for an overall rejection rate of 83.7% or at a rate of 1.25 episodes/patient with rejection. The rate of ACR was three times as great in those who remained alcohol-abstinent (2.24 episodes/patient), compared with those who admitted to continued alcohol use (0.75 episodes/patient) (p < 0.01). A total of 33 episodes of chronic rejection occurred in 26 patients, for an overall rate of 12.4%. As was the case for ACR, the chronic rejection rate was greater among those who were continuously alcohol-abstinent, compared with those who intermittently used alcohol after successful LTx. There were no differences in the mean FK 506 or cyclosporin A levels in the groups with and without a rejection episode at the time the rejection episode was documented by liver biopsy.(ABSTRACT TRUNCATED AT 250 WORDS)
酒精性肝病是肝病的主要病因,并且已成为肝脏移植(LTx)日益增多的适应症。随访研究报告称,与因终末期酒精相关性肝硬化接受移植的患者相比,因酒精性肝炎接受移植的患者酒精复饮率更高。人们普遍认为,复饮酒精与免疫抑制依从性降低有关,因此移植排斥和移植物丢失风险增加。为评估这一问题,对1986年1月1日至1991年12月31日期间因酒精性肝炎合并肝硬化或仅因肝硬化接受移植的209例酒精性患者进行了随访,平均随访时间为4.4±0.6年。137例患者发生了175次急性细胞排斥反应(ACR),总体排斥率为83.7%,即排斥患者的发生率为1.25次/患者。戒酒者的ACR发生率(2.24次/患者)是承认继续饮酒者(0.75次/患者)的三倍(p<0.01)。26例患者共发生33次慢性排斥反应,总体发生率为12.4%。与ACR情况一样,持续戒酒者的慢性排斥率高于肝移植成功后间歇性饮酒者。在通过肝活检记录排斥反应时,有排斥反应和无排斥反应的两组患者的平均FK 506或环孢素A水平没有差异。(摘要截短于250字)